×
About 1,148 results

ALLMedicine™ Botulism Center

Research & Reviews  370 results

CBRNE - Botulism
https://emedicine.medscape.com/article/829125-print

Feb 23rd, 2023 - Practice Essentials Botulism is a paralytic disease caused by the neurotoxins of Clostridium botulinum and, in rare cases, C butyricum and C baratii. These gram-positive spore-forming anaerobes can be found in soil samples and marine sediments thr...

CBRNE - Botulism
http://emedicine.medscape.com/article/829125-overview

Feb 23rd, 2023 - Practice Essentials Botulism is a paralytic disease caused by the neurotoxins of Clostridium botulinum and, in rare cases, C butyricum and C baratii. These gram-positive spore-forming anaerobes can be found in soil samples and marine sediments thr...

CBRNE - Botulism
https://emedicine.medscape.com/article/829125-overview

Feb 23rd, 2023 - Practice Essentials Botulism is a paralytic disease caused by the neurotoxins of Clostridium botulinum and, in rare cases, C butyricum and C baratii. These gram-positive spore-forming anaerobes can be found in soil samples and marine sediments thr...

Effects of EMG-driven Robot-assisted Therapy for the Distal Upper Limb Motor Function in the Chronic Stroke Patients With Botox Injections
https://clinicaltrials.gov/ct2/show/NCT04502264

Feb 13th, 2023 - Over fifty percent of stroke patients experience chronic arm hand performance problems, compromising independence in daily life activities and quality of life. Traditionally, the effectiveness of rehabilitation in improving functioning for stroke ...

Iatrogenic Botulism: A Case Treated With Botulinum Antitoxin.
https://doi.org/10.1097/WNF.0000000000000535
Clinical Neuropharmacology; Gonul Oner O, Gudek HC et. al.

Feb 3rd, 2023 - Botulinum toxin type A is widely used for the treatment of spasticity, focal dystonia, hemifacial spasm, hyperhidrosis, strabismus, chronic migraine, and also cosmetic purposes. Therapeutic use is commonly effective and safe. However, if toxin ent...

see more →

Drugs  8 results see all →

Clinicaltrials.gov  17 results

Effects of EMG-driven Robot-assisted Therapy for the Distal Upper Limb Motor Function in the Chronic Stroke Patients With Botox Injections
https://clinicaltrials.gov/ct2/show/NCT04502264

Feb 13th, 2023 - Over fifty percent of stroke patients experience chronic arm hand performance problems, compromising independence in daily life activities and quality of life. Traditionally, the effectiveness of rehabilitation in improving functioning for stroke ...

BT-011 Pharmacokinetics of Botulism Antitoxin Heptavalent in Pediatric Patients
https://clinicaltrials.gov/ct2/show/NCT02051062

Jan 31st, 2023 - Primary Objective: To collect blood from pediatric participants to analyze the pharmacokinetics (PK) of BAT product to verify the current US FDA-approved pediatric dosing recommendations for BAT product. Safety Objective: To evaluate the safety of...

Evaluation of the Improvement of Quality of Life of Patients Suffering From Hailey Hailey or Darier Disease After Injections of Botulism Toxin Into Large Folds.
https://clinicaltrials.gov/ct2/show/NCT02782702

Dec 13th, 2021 - Hailey Hailey and Darier disease are rare genetic dermatoses. Mutations of 2 genes (ATP2C1 or ATP2A2 respectively) are responsible for the diseases. These genes have a key role in calcium pump; their defect create abnormal link between keratinocyt...

Functional Outcome of Hemiplegic Upper Extremity in Patients With Subacute Stroke After Kinesiotaping and Rehabilitation
https://clinicaltrials.gov/ct2/show/NCT04027985

Jul 29th, 2021 - Clinical characteristics of impaired motor performance on affected upper extremity in stroke patients included muscle weakness, increased muscle tone, contracture, joint instability, or impaired motor control. Poststroke spasticity (PSS) is also a...

BT-010 Registry for the Evaluation of Safety and Clinical Outcomes in Patients Treated With Botulinum Antitoxin
https://clinicaltrials.gov/ct2/show/NCT02055183

Feb 17th, 2021 - A full description of the patient registry can be found in the paper titled: Safety and Clinical Outcomes of an Equine-derived Heptavalent Botulinum Antitoxin Treatment for Confirmed or Suspected Botulism in the United States. Richardson JS, Parre...

see more →

News  52 results

Synopsis - Infant Botulism, Israel, 2007-2021
https://tools.cdc.gov/medialibrary/index.aspx#/media/id/733534

cases indicate a stronger link to soil transmission, possible seasonal variation, and a milder course of disease.

Botulism
https://tools.cdc.gov/medialibrary/index.aspx#/media/id/285333

Have you ever heard of a foodborne disease that causes paralysis? How can you prevent this from happening to you or your family?

20th anniversary and history of cosmetic botulinum toxin type A
https://www.mdedge.com/dermatology/article/254808/aesthetic-dermatology/20th-anniversary-and-history-cosmetic-botulinum
Naissan O. Wesley, MD

May 20th, 2022 - Historical food-borne outbreaks of botulism and identification of Clostridium botulinum as the bacterium responsible have had an enormous impact in medicine related to its therapeutic and cosmetic uses. The timeline of botulinum toxin discovery be.

Testing for LEMS
https://www.onclive.com/view/testing-for-lems

Dec 21st, 2021 - David Gerber, MD: Steve, it might be helpful at this point to go over how we diagnose and test for LEMS [Lambert-Eaton myasthenic syndrome]. Steven Vernino, MD, PhD: As neurologists, when we see conditions that make us think about paraneoplastic ...

New Botulism Guidelines Focus on Mass-Casualty Events
https://www.medscape.com/viewarticle/952251

Jun 1st, 2021 - Botulinum toxin is said to be the most lethal substance known. Inhaling just 1-3 nanograms of toxin per kilogram of body mass constitutes a lethal dose.  Now the Centers for Disease Control and Prevention (CDC) has published the first comprehensiv...

see more →

Patient Education  12 results see all →